blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3790870

EP3790870 - CYCLOPENTANE COMPOUNDS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  23.02.2024
Database last updated on 12.10.2024
FormerThe patent has been granted
Status updated on  17.03.2023
FormerGrant of patent is intended
Status updated on  20.12.2022
FormerRequest for examination was made
Status updated on  12.02.2021
FormerThe international publication has been made
Status updated on  16.11.2019
Formerunknown
Status updated on  24.05.2019
Most recent event   Tooltip17.05.2024Lapse of the patent in a contracting state
New state(s): BE, SI
published on 19.06.2024  [2024/25]
Applicant(s)For all designated states
DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.
Huirong Business E Building
East Jinghui Road
Wuxi City, Jiangsu Province / CN
[2023/16]
Former [2021/11]For all designated states
DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD
Huirong Business E Building
East Jinghui Road
Wuxi City, Jiangsu Province / CN
Inventor(s)01 / ZHANG, Xiaolin
1 Francis Crick Avenue Cambridge Biomedical
Campus
Cambridge Cambridgeshire CB2 0AA / GB
02 / PAN, Weitao
1 Francis Crick Avenue Cambridge Biomedical
Campus
Cambridge Cambridgeshire CB2 0AA / GB
03 / NIKITIDIS, Grigorios
Forskargatan 18
151 85 Södertälje / SE
04 / LINDHAGEN, Jenny, Susanna, Marika
Forskargatan 18
151 85 Södertälje / SE
 [2023/16]
Former [2021/11]01 / PAN, Weitao
1 Francis Crick Avenue Cambridge Biomedical
Campus
Cambridge Cambridgeshire CB2 0AA / GB
02 / NIKITIDIS, Grigorios
151 85 Södertälje / SE
03 / LINDHAGEN, Jenny, Susanna, Marika
151 85 Södertälje / SE
04 / ZHANG, Xiaolin
1 Francis Crick Avenue Cambridge Biomedical
Campus
Cambridge Cambridgeshire CB2 0AA / GB
Representative(s)Simmons & Simmons LLP (Munich), et al
Lehel Carré
Gewürzmühlstraße 11
80538 Munich / DE
[N/P]
Former [2023/16]Lahrtz, Fritz, et al
Simmons & Simmons LLP
Lehel Carré Thierschplatz 6
80538 München / DE
Former [2021/11]Lahrtz, Fritz
Patentanwälte
Isenbruck Bösl Hörschler PartG mbB
Prinzregentenstraße 68
81675 München / DE
Application number, filing date19724152.409.05.2019
[2021/11]
WO2019EP61888
Priority number, dateWO2018CN8650311.05.2018         Original published format: PCT/CN2018/086503
[2021/11]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019215268
Date:14.11.2019
Language:EN
[2019/46]
Type: A1 Application with search report 
No.:EP3790870
Date:17.03.2021
Language:EN
The application published by WIPO in one of the EPO official languages on 14.11.2019 takes the place of the publication of the European patent application.
[2021/11]
Type: B1 Patent specification 
No.:EP3790870
Date:19.04.2023
Language:EN
[2023/16]
Search report(s)International search report - published on:EP14.11.2019
ClassificationIPC:C07D401/08, C07D211/56, A61P13/12, A61K31/451, A61K31/454, A61K31/4545
[2021/11]
CPC:
C07D401/08 (EP,KR,US); A61K31/454 (KR); A61P13/12 (EP,KR,US);
C07D211/56 (EP,KR); C07B2200/13 (US); Y02P20/55 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/11]
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:CYCLOPENTANVERBINDUNGEN[2021/11]
English:CYCLOPENTANE COMPOUNDS[2021/11]
French:COMPOSÉS DE CYCLOPENTANE[2021/11]
Entry into regional phase07.12.2020National basic fee paid 
07.12.2020Designation fee(s) paid 
07.12.2020Examination fee paid 
Examination procedure07.12.2020Examination requested  [2021/11]
07.12.2020Date on which the examining division has become responsible
13.04.2021Amendment by applicant (claims and/or description)
21.12.2022Communication of intention to grant the patent
03.03.2023Fee for grant paid
03.03.2023Fee for publishing/printing paid
03.03.2023Receipt of the translation of the claim(s)
Opposition(s)22.01.2024No opposition filed within time limit [2024/13]
Fees paidRenewal fee
11.05.2021Renewal fee patent year 03
23.05.2022Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCZ19.04.2023
EE19.04.2023
FI19.04.2023
HR19.04.2023
LT19.04.2023
LV19.04.2023
MC19.04.2023
PL19.04.2023
RO19.04.2023
RS19.04.2023
SI19.04.2023
SK19.04.2023
SM19.04.2023
LU09.05.2023
BE31.05.2023
GR20.07.2023
IS19.08.2023
[2024/25]
Former [2024/10]CZ19.04.2023
EE19.04.2023
FI19.04.2023
HR19.04.2023
LT19.04.2023
LV19.04.2023
MC19.04.2023
PL19.04.2023
RO19.04.2023
RS19.04.2023
SK19.04.2023
SM19.04.2023
LU09.05.2023
GR20.07.2023
IS19.08.2023
Former [2024/09]CZ19.04.2023
FI19.04.2023
HR19.04.2023
LT19.04.2023
LV19.04.2023
MC19.04.2023
PL19.04.2023
RS19.04.2023
SK19.04.2023
SM19.04.2023
LU09.05.2023
GR20.07.2023
IS19.08.2023
Former [2024/08]FI19.04.2023
HR19.04.2023
LT19.04.2023
LV19.04.2023
PL19.04.2023
RS19.04.2023
SK19.04.2023
SM19.04.2023
LU09.05.2023
GR20.07.2023
IS19.08.2023
Former [2024/03]FI19.04.2023
HR19.04.2023
LT19.04.2023
LV19.04.2023
PL19.04.2023
RS19.04.2023
GR20.07.2023
IS19.08.2023
Former [2024/01]HR19.04.2023
LT19.04.2023
LV19.04.2023
PL19.04.2023
RS19.04.2023
GR20.07.2023
IS19.08.2023
Former [2023/51]HR19.04.2023
PL19.04.2023
RS19.04.2023
GR20.07.2023
IS19.08.2023
Former [2023/50]PL19.04.2023
GR20.07.2023
IS19.08.2023
Cited inInternational search[A]EP2368876  (SANOFI SA [FR])
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.